HealthyDirect · Growth
Nippon India Pharma Fund
Nippon India Mutual FundEquity Schemes - Sectoral Fund13.7 years
- NAV
- 632.1723
- 15 Sept 2026
- 1Y
- +9.6%
- Trailing CAGR
- AUM
- ₹9,279.11 Cr
- 31 Aug 2026
- Volatility
- Medium
- 15.4% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+9.6%
- 3Y+17.6%
- 5Y+13.1%
- 10Y+15.6%
- SI+17.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+15.1%
- 3Y+12.5%
- 5Y+17.0%
- 10Y+18.5%
- Since inception
- +17.4%
- Calendar-day CAGR
- Excess 1Y
- +1.5%
- Category median, same plan and option
- 3Y win rate
- +40%
- Windows beating the median
- 3Y percentile
- 63
- Vs comparable share classes
- Worst rolling 3Y
- -1.4%
- 2637 daily-ending windows
- Median rolling 3Y
- +19.9%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2144 daily-ending windows
- SIP 3Y XIRR
- +12.5%
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 15 days
- 143 recovered episodes
- Longest recovery
- 445 days
- Trough to prior peak
- Current spell
- 15 days
- Days below latest peak
- Time below peak
- +90%
- NAV observations
30 Oct 2015 – 17 Aug 2018
Trough 29 May 2017 · recovered in 445 days
-24.0%
19 Feb 2020 – 9 Apr 2020
Trough 23 Mar 2020 · recovered in 17 days
-21.2%
15 Sept 2021 – 28 Jun 2023
Trough 17 Jun 2022 · recovered in 376 days
-19.5%
7 Sept 2018 – 19 Feb 2020
Trough 7 Oct 2019 · recovered in 135 days
-17.4%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
63
Vs category
60
Consistency
41
Risk-adjusted
65
Drawdown
40
Mean
54
Portfolio
31 Aug 2026 · 38 holdings · top 10 are 57.3%.
- Top 5
- 38.4%
- Top 10
- 57.3%
- Largest holding
- 12.4%
- Effective holdings
- 21.2
Sun Pharmaceutical Industries Ltd
Healthcare
12.4%
Divi's Laboratories Ltd
Healthcare
7.0%
Lupin Ltd
Healthcare
6.4%
Cipla Ltd
Healthcare
6.1%
Apollo Hospitals Enterprise Ltd
Healthcare
5.1%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
DSP Healthcare Fund
DSP Mutual Fund
- 1Y
- +14.1%
- 3Y
- +20.8%
- Vol
- 14.4%
- Max DD
- -21.7%
- Sharpe
- 1.19
- 3Y win
- +59%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
WhiteOak Capital Pharma and Healthcare Fund
WhiteOak Capital Mutual Fund
- 1Y
- +22.7%
- 3Y
- n/a
- Vol
- 14.3%
- Max DD
- -15.4%
- Sharpe
- 1.26
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
BANDHAN TRANSPORTATION AND LOGISTICS FUND
Bandhan Mutual Fund
- 1Y
- +4.7%
- 3Y
- +18.4%
- Vol
- 14.7%
- Max DD
- -25.0%
- Sharpe
- 1.04
- 3Y win
- +83%
- Lower volatility
- Higher win rate vs category
- Higher trailing returns
Caveat: Deeper drawdown
DSP Banking & Financial Services Fund
DSP Mutual Fund
- 1Y
- +15.2%
- 3Y
- n/a
- Vol
- 16.7%
- Max DD
- -14.7%
- Sharpe
- 0.73
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Lower trailing returns
Groww Banking & Financial Services Fund
Groww Mutual Fund
- 1Y
- +12.6%
- 3Y
- n/a
- Vol
- 16.0%
- Max DD
- -16.4%
- Sharpe
- 0.50
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Lower trailing returns